Orchid Pharma antibiotic API plant passes US FDA inspection

By Gareth Macdonald contact

- Last updated on GMT

Related tags: Pharmaceutical drug

Orchid Pharma antibiotic API plant passes US FDA inspection
API firm Orchid Pharma has passed a US Food and Drug Administration (FDA) inspection at its facility in Tamil Nadu, India.

The facility in Alathur was visited by the US regulator last August according to Orchid, which announced it received an FDA Establishment Inspection Report (EIR) in a filing​ on the Bombay Stock Exchange (BSE) today. 

Orchid makes antibiotic active pharmaceutical ingredients (APIs) – primarily cephalosporin - at the site.

Operations at the facility were suspending in December​ as a result of flooding, which had a negative impact on the firm according to managing director K Raghavendra Rao.

Despite the business interruption sustained on account of unprecedented torrential rains in December 2015, the company is confident of regaining the traction on account of growth measures being initiated including launch of new products and long term financial arrangements​.”

Related news

Show more

Related products

show more

Facilities: Grangemouth, UK

Facilities: Grangemouth, UK

Piramal Pharma Solutions | 28-Jun-2021 | Insight Guide

The Piramal Pharma Solutions site in Grangemouth, UK offers development, clinical & commercial scale manufacture of bio-conjugates including Antibody...

Facilities: Aurora, Canada

Facilities: Aurora, Canada

Piramal Pharma Solutions | 28-Jun-2021 | Insight Guide

The Piramal Pharma Solutions facility in Aurora Canada offers development, clinical and commercial GMP manufacturing of Active Pharmaceutical Ingredients...

Integrated Solutions for Accelerated Time to Market

Integrated Solutions for Accelerated Time to Market

Piramal Pharma Solutions | 08-Jun-2021 | Technical / White Paper

Facing capacity constraints? Lock in your program now! With 14 sites around the world providing diverse services ranging from discovery to drug substance...

Related suppliers

Follow us

Products

View more

Webinars